| __timestamp | Celldex Therapeutics, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 581800000 |
| Thursday, January 1, 2015 | 100171000 | 671900000 |
| Friday, January 1, 2016 | 102726000 | 876700000 |
| Sunday, January 1, 2017 | 96171000 | 857900000 |
| Monday, January 1, 2018 | 66449000 | 822200000 |
| Tuesday, January 1, 2019 | 42672000 | 778200000 |
| Wednesday, January 1, 2020 | 42534000 | 512600000 |
| Friday, January 1, 2021 | 53311000 | 681000000 |
| Saturday, January 1, 2022 | 82258000 | 662200000 |
| Sunday, January 1, 2023 | 118011000 | 910700000 |
Infusing magic into the data realm
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Viatris Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Viatris consistently outspent Celldex, with its R&D expenses peaking at approximately 910% higher than Celldex's in 2023. This disparity highlights Viatris's robust financial commitment to innovation, despite Celldex's notable 38% increase in R&D spending from 2020 to 2023. While Viatris's spending reflects its larger scale and broader market reach, Celldex's focused investments underscore its strategic efforts in niche therapeutic areas. As the pharmaceutical industry continues to prioritize innovation, these spending patterns offer valuable insights into each company's strategic priorities and potential future breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Celldex Therapeutics, Inc.
Research and Development Investment: Johnson & Johnson vs Viatris Inc.
Research and Development: Comparing Key Metrics for Pfizer Inc. and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Neurocrine Biosciences, Inc. and Viatris Inc.
Viatris Inc. or BioMarin Pharmaceutical Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Viatris Inc. vs Alkermes plc
R&D Spending Showdown: Viatris Inc. vs Wave Life Sciences Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and BioCryst Pharmaceuticals, Inc.
PTC Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Galapagos NV vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Celldex Therapeutics, Inc. vs Novavax, Inc.
Research and Development Investment: Celldex Therapeutics, Inc. vs Evotec SE